Meet the Programme Commitee for DIA Europe 2024!

Aimad Torqui • Head of Division Medicines Evaluation Board
MEB, Netherlands

Álmath Máire Spooner, PhD, RPh • Chair
EFPIA IEGU working group, Belgium

Bianca Mulder, PharmD, MPharm, MSc • Pharmacovigilance Assessor
Medicines Evaluation Board, Netherlands

Claudia Dollins, PhD, RAC • Vice President, Precision Medicines, Global Regulatory Affairs
GlaxoSmithKline, United States

Dima Samaha • Senior Principal, EMEA Value & Payer Evidence
IQVIA, United Kingdom

Douglas Gregory • Senior Director, Government Affairs Strategy and Excellence
Bristol Myers Squibb, Belgium

Emma Du Four, MBA • Head of International Regulatory Policy
AbbVie, United Kingdom

James Whitehead, MSc • Patient Safety Medical Device Lead
Astrazeneca, United Kingdom

James Ryan, MSc • Global Director, HTA Policy
AstraZeneca (Global), UK, United Kingdom

Julie O'Brien, PhD • Senior Director, Head EuCANZ Regulatory Policy
Pfizer Inc; EFPIA, Ireland

Marianne Lunzer, DrMed • Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
AGES, Austria

Matt Popkin, PhD • Senior Director, CMC Excellence, Global Regulatory Affairs
GlaxoSmithKline, United Kingdom

Michela Gabaldo, PharmD, MSc • VP ATMP Global Regulatory Affairs
Evotec, Italy

Mireille Muller, DrSc, PhD, MSc • Regulatory Policy & Intelligence Director
Novartis Pharma AG, Switzerland

Momir Radulovic • Executive Director
Slovenian Medicines and Medical Devices Agency (JAZMP), Slovenia

Rabia Kahveci • Senior Technical Advisor
Management Sciences for Health, Ukraine

Rodrigo Palacios, MBA • Regulatory Policy Lead
F. Hoffmann-La Roche, Switzerland

Ronnie Harprit Mundair • Regional Labelling Head - AfME, Canada and LATAM - Senior Director
Pfizer, United Kingdom

Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands

Sini Eskola, MPharm, MS, MSc • Director Regulatory Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium

Sofia Ribeiro • Head Regulatory Affairs CMC
Bayer US LLC, United States

Sophie Schmitz • Managing Partner
P4A Partners for Access, Netherlands

Thomas W. Moller, MBA, MSc • Director Global Regulatory Affairs - Devices
Novo Nordisk, Denmark

Tim Chesworth • Senior Director Regulatory Affairs
AstraZeneca, United Kingdom

Valentina Strammiello, MA • Director of Programmes
European Patients' Forum, Belgium

Virginia Acha, PhD, MSc • AVP, Global Regulatory Policy
Merck Sharp & Dohme LLC, United Kingdom

Program Committee